Ignite Creation Date:
2025-12-24 @ 12:06 PM
Ignite Modification Date:
2026-02-21 @ 11:18 PM
Study NCT ID:
NCT03660761
Status:
COMPLETED
Last Update Posted:
2019-04-16
First Post:
2018-08-11
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Apatinib in Recurrent or Refractory Intracranial Central Nervous System Malignant Tumors
Sponsor:
Rongjie Tao
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
ShandongCHI005
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None